INCRELEX

ipsen biopharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 69ac609693f4b206
Drug Approval Canada Name: INCRELEX
Product Name: INCRELEX
Status: Marketed
Status Date: 2021-03-01
Original Market Date: 2021-03-01
Din: 02509733
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 68:30.04
Atc Original: H01AC03 MECASERMIN
Atc Name: h 01 ac 03
Aig Number: 0162642001
Company Name: ipsen biopharmaceuticals canada inc
Company Address: SUITE 500, 5050 Satellite Drive, Mississauga, Ontario, Canada, L4W 0G1

MECASERMIN

40 MG / 4 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

69ac609693f4b206

Type

Standard